FILTRIX Logo FILTRIX Find Your Edge →

Latest signal:

CBIO Stock Analysis

Data source: Trade-Ideas Alerts | 37 alerts analyzed | Backtest period: 2022-01-06 → 2023-06-23

⚠️ Small sample size (37 alerts). Statistics may have high variance. Interpret with caution.

🏢 Company Profile

Crescent Biopharma, Inc. Common Stock PHARMACEUTICAL PREPARATIONS (SIC 2834)
📍 NASDAQ 📅 IPO: Jun 16, 2025 🔗 www.crescentbiopharma.com
💰 Market Cap: $389.7M
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent believes CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. Crescent is advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.
📊
37
Total Alerts
🎯
78.4%
Win Rate (EOD)
💰
+828.92%
Avg Gain (EOD)
🚀
+9.42%
Avg MFE (Max Potential)

📈 Performance by Timeframe

5MIN

Win Rate: 45.9%
Avg Gain: +0.42%
Avg Winner: +2.75%
Avg Loser: -1.74%
Best: +7.04%
Worst: -6.25%
Trades: 17/18

15MIN

Win Rate: 62.2%
Avg Gain: +0.87%
Avg Winner: +3.52%
Avg Loser: -3.75%
Best: +11.79%
Worst: -8.63%
Trades: 23/13

30MIN

Win Rate: 43.2%
Avg Gain: +0.71%
Avg Winner: +6.30%
Avg Loser: -4.13%
Best: +27.27%
Worst: -15.41%
Trades: 16/18

60MIN

Win Rate: 43.2%
Avg Gain: -0.19%
Avg Winner: +4.91%
Avg Loser: -4.27%
Best: +15.10%
Worst: -23.21%
Trades: 16/20

EOD (End of Day)

Win Rate: 78.4%
Avg Gain: +828.92%
Avg Winner: +1058.80%
Avg Loser: -4.40%
Best: +1928.75%
Worst: -7.86%
Trades: 29/8

🚀 Max Favorable / Adverse Excursion (MFE/MAE)

Institutional-grade metrics showing the maximum profit potential and risk for each alert.

📈 MFE (Max Profit Potential)

Average MFE: +9.42%
Best MFE: +63.82%
Avg Time to MFE: 113 min

On average, CBIO alerts reach +9.42% profit potential within 113 minutes.

📉 MAE (Max Drawdown Risk)

Average MAE: -2.24%
Worst MAE: -7.86%
Avg Time to MAE: 15 min

Before reaching MFE, expect an average drawdown of 2.24%.

⚖️ Risk/Reward Ratio

4.2:1

Excellent risk/reward - potential gain is 4.2x the typical drawdown.

💡 Trading Insight: Based on 37 alerts, CBIO typically reaches +9.42% profit before pulling back. Consider setting profit targets around 7.5% to capture most of the move.

🌅 Premarket Gap Analysis (9:25 → 9:30)

Total Gaps Analyzed 37
Gap Up % 45.9%
Avg Gap +0.13%
Best Gap +4.84%

🏭 Sector Comparison: PHARMACEUTICAL PREPARATIONS

How CBIO compares to 381 other tickers in the same sector.

5-Min Gain
CBIO: +0.42% Sector: -0.32% +0.73%
EOD Gain
CBIO: +828.92% Sector: +4480411.22% -4479582.30%
Avg MFE
CBIO: +9.42% Sector: +7.56% +1.87%

📋 Last 20 Alerts

Historical CBIO alerts with performance metrics calculated from 1-minute price data. Each row shows the actual price movement at different timeframes after the alert.

Date Time Price 5min 15min 30min 60min EOD MFE MAE Gap Result
2023-06-23 09:28:00 $0.3 +7.04% +1.08% +2.53% -0.67% -0.20% +7.04% -0.03% +1.01% WIN
2023-06-22 09:27:00 $0.35 +0.34% +3.21% +4.04% +3.47% +1267.15% +5.73% - +0.32% WIN
2023-06-21 09:29:00 $0.3 +2.37% +6.91% +27.27% +15.10% +1622.04% +63.82% -1.32% +1.97% WIN
2023-03-13 09:28:00 $0.21 -3.52% -4.70% -3.52% +1.25% +1420.26% +6.13% -7.86% -1.59% LOSS
2023-03-10 09:28:00 $0.21 +2.37% +4.42% +6.37% +0.65% -7.86% +6.98% +2.33% +2.33% WIN
2023-03-07 09:27:00 $0.25 - +0.24% -1.55% -3.79% +1393.27% +1.31% -0.04% +1.18% -
2023-03-06 09:26:00 $0.24 +0.75% -1.80% -3.30% -2.68% +1405.65% +8.28% -3.39% +0.38% WIN
2023-03-03 09:25:00 $0.24 +1.74% +2.88% +3.39% +2.63% +0.30% +4.92% - +1.69% WIN
2023-03-02 09:27:00 $0.24 -0.46% -0.08% +2.07% +1.37% +0.95% +7.29% -2.20% +2.15% LOSS
2023-03-01 09:29:00 $0.27 -1.89% - -1.96% -1.89% -6.94% - -1.77% - LOSS
2023-02-28 09:26:00 $0.35 -5.15% -8.63% -15.41% -11.21% +1180.91% +0.63% -0.95% -1.67% LOSS
2023-02-02 09:28:00 $0.3 +1.84% +1.94% +0.17% +0.17% +1424.54% +6.84% -1.47% -1.47% WIN
2023-01-20 09:28:00 $0.25 +4.84% +4.40% +9.64% +8.23% +7.50% +10.81% -0.81% +4.84% WIN
2023-01-17 09:28:00 $0.26 +1.73% +4.08% +2.88% - -2.04% +7.31% -1.92% +3.85% WIN
2023-01-13 09:29:00 $0.28 -3.71% -5.39% -15.36% -23.21% -6.25% +3.57% -2.14% -1.68% LOSS
2023-01-04 09:29:00 $0.59 +1.33% +1.38% +2.21% +1.40% +1433.22% +3.92% +0.51% +1.19% WIN
2022-12-27 09:25:00 $0.52 +5.77% +3.85% +0.96% +3.85% +1377.79% +5.77% +3.85% +3.85% WIN
2022-09-23 09:25:00 $0.54 - -7.41% -5.50% -6.44% +1259.44% +1.85% -0.02% - -
2022-09-22 09:25:00 $0.5 -0.22% +1.80% -0.12% -2.00% +3.90% +6.00% -3.54% - LOSS
2022-09-21 09:25:00 $0.54 -0.72% +0.02% -1.69% -2.17% -7.30% +4.61% -2.67% -0.72% LOSS

Table Metrics Explained:

  • 5min/15min/30min/60min/EOD: Price change at each timeframe (calculated from real minute-by-minute data)
  • MFE: Maximum Favorable Excursion - highest profit potential reached during the day
  • MAE: Maximum Adverse Excursion - worst drawdown experienced before reaching MFE
  • Gap: Premarket price gap from 9:25 AM to 9:30 AM market open
  • Result: WIN if 5min change > 0%, LOSS otherwise

🚀 Beat the 78.4% Baseline on CBIO

The 78.4% win rate is just the raw starting point. Launch the app to apply filters (Volume, RSI, Time) and see if you can push CBIO's performance to 75%+.

Optimize CBIO Strategy →

Why Analyze CBIO with FILTRIX?

🛡️ Realistic Entry Simulation

We don't inflate stats. Our analysis tracks only the first alert of the day for CBIO. This simulates a true "Gap & Go" entry at pre-market hours (9:25-9:30 AM), avoiding the trap of chasing a stock that has already extended.

💰 Max Potential (MFE) Analysis

How much is left in the move? On winning days, CBIO historically offers an average upside of +9.42% intraday. Our data helps you distinguish between a quick scalp and a runner.

📊 CBIO Momentum Personality

With a baseline win rate of 78.4%, CBIO shows strong follow-through, making it a prime candidate for momentum strategies.

⏱️ Optimized Exit Timing

Don't guess when to sell. Our backtests show CBIO performs best on the EOD (End of Day) timeframe (Avg Gain: +828.92%), signaling that gains often fade later in the session.